These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37958824)

  • 1. Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients.
    Cho J; Horikawa Y; Oiwa Y; Hosomichi K; Yabe D; Imai T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UDP-Glucose: A Cereblon-Dependent Glucokinase Protein Degrader.
    Cho J; Miyagawa A; Yamaguchi K; Abe W; Tsugawa Y; Yamamura H; Imai T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathogenic variant in the glucokinase gene found in two Japanese siblings with maturity-onset diabetes of the young 2.
    Tanaka S; Akagawa H; Azuma K; Watanabe K; Higuchi S; Iwasaki N
    Endocr J; 2023 Jun; 70(6):629-634. PubMed ID: 37045781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UDP-glucose, cereblon-dependent proinsulin degrader.
    Cho J; Miyagawa A; Yamaguchi K; Abe W; Tsugawa Y; Yamamura H; Imai T
    Sci Rep; 2022 Aug; 12(1):14568. PubMed ID: 36028536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of two MODY2 mutations with different susceptibility to activation.
    Langer S; Platz C; Waterstradt R; Baltrusch S
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1113-1119. PubMed ID: 26208450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
    Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
    Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maturity-onset diabetes of the young 2 with a novel mutation of glucokinase gene in a Chinese boy and the clinical follow-up].
    Li X; Liu L; Liang C; Sheng H; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):867-71. PubMed ID: 25582477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells.
    Cho J; Horikawa Y; Enya M; Takeda J; Imai Y; Imai Y; Handa H; Imai T
    Commun Biol; 2020 Sep; 3(1):497. PubMed ID: 32901087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing.
    García-Herrero CM; Rubio-Cabezas O; Azriel S; Gutierrez-Nogués A; Aragonés A; Vincent O; Campos-Barros A; Argente J; Navas MA
    PLoS One; 2012; 7(1):e30518. PubMed ID: 22291974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
    Massa O; Meschi F; Cuesta-Munoz A; Caumo A; Cerutti F; Toni S; Cherubini V; Guazzarotti L; Sulli N; Matschinsky FM; Lorini R; Iafusco D; Barbetti F;
    Diabetologia; 2001 Jul; 44(7):898-905. PubMed ID: 11508276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
    Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2).
    Martin D; Bellanné-Chantelot C; Deschamps I; Froguel P; Robert JJ; Velho G
    Diabetes Care; 2008 Jul; 31(7):1321-3. PubMed ID: 18411240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
    Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
    Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity.
    Aránguiz O; Rivera R; Durruty P; Seelenfreund D; Báez M
    FEBS Lett; 2023 Jun; 597(11):1469-1478. PubMed ID: 36520489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturity onset diabetes of the young type 2 (MODY2): Insight from an extended family.
    Elias-Assad G; Saab R; Molnes J; Hess O; Abu-Ras R; Darawshi H; Rasmus Njølstad P; Tenenbaum-Rakover Y
    Diabetes Res Clin Pract; 2021 May; 175():108791. PubMed ID: 33812904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
    Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
    Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
    Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
    Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MODY2 caused by a novel mutation of GCK gene.
    Pulst K; Arbo T; Kahre T; Peet A; Tillmann V
    J Pediatr Endocrinol Metab; 2012; 25(7-8):801-3. PubMed ID: 23155715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.